Stockreport

Intravascular Ultrasound (IVUS) Global Strategic Business Report 2025-2030 - Cumulative Revenues to Cross $1.1 Billion by 2030 Driven by Patients' Growing Preference for MIS [Yahoo! Financ...

Johnson & Johnson  (JNJ) 
Last johnson & johnson earnings: 4/14 06:31 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
PDF 8.4%. The IVUS Consoles segment is also set to grow at 6.7% CAGR over the analysis period. Dublin, April 24, 2025 (GLOBE NEWSWIRE) -- The "Intravascular Ultrasound (IV [Read more]